Unfortunately its the best indication we have of the value of the company at the moment and until some confidence is restored it will likely head further south. Anyone who thinks this value loss is transitory or based on current cost of living pressure is certifiably DELUSIONAL imho.
IMO there is ZERO chance of an IPO or a liquidity event at all while there is apparent conflict at the Board and no CEO appointed. And, an IPO seems to be predicated on doing a licensing or development deal with big Pharma and odds are low that this will be done anytime this year or at all given the rapid rise of CAR-T and other more interesting and efffective technologies. Your best hope@Alf107 is a takeover bid by a consolidator that has a proven track record it can get shit done.
